Literature DB >> 29944741

Combined neuropathological pathways account for age-related risk of dementia.

Melinda C Power1, Elizabeth Mormino2, Anja Soldan3, Bryan D James4,5, Lei Yu6, Nicole M Armstrong7, Katherine J Bangen8,9, Lisa Delano-Wood8,9, Melissa Lamar4,10, Yen Ying Lim11, Kelly Nudelman12, Laura Zahodne13, Alden L Gross7,14,15, Dan Mungas16, Keith F Widaman17, Julie Schneider4,6,18.   

Abstract

OBJECTIVE: Our objectives were to characterize the inter-relation of known dementia-related neuropathologies in one comprehensive model and quantify the extent to which accumulation of neuropathologies accounts for the association between age and dementia.
METHODS: We used data from 1,362 autopsied participants of three community-based clinicopathological cohorts: the Religious Orders Study, the Rush Memory and Aging Project, and the Minority Aging Research Study. We estimated a series of structural equation models summarizing a priori hypothesized neuropathological pathways between age and dementia risk individually and collectively.
RESULTS: At time of death (mean age, 89 years), 44% of our sample had a clinical dementia diagnosis. When considered individually, our vascular, amyloid/tau, neocortical Lewy body, and TAR DNA-binding protein 43 (TDP-43)/hippocampal sclerosis pathology pathways each accounted for a substantial proportion of the association between age and dementia. When considered collectively, the four pathways fully accounted for all variance in dementia risk previously attributable to age. Pathways involving amyloid/tau, neocortical Lewy bodies, and TDP-43/hippocampal sclerosis were interdependent, attributable to the importance of amyloid beta plaques in all three. The importance of the pathways varied, with the vascular pathway accounting for 32% of the association between age and dementia, wheraes the remaining three inter-related degenerative pathways together accounted for 68% (amyloid/tau, 24%; the Lewy body, 1%; and TDP-43/hippocampal sclerosis, 43%).
INTERPRETATION: Age-related increases in dementia risk can be attributed to accumulation of multiple pathologies, each of which contributes to dementia risk. Multipronged approaches may be necessary if we are to develop effective therapies. Ann Neurol 2018;84:10-22.
© 2018 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29944741      PMCID: PMC6119518          DOI: 10.1002/ana.25246

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

1.  The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia.

Authors:  Lisa L Barnes; Raj C Shah; Neelum T Aggarwal; David A Bennett; Julie A Schneider
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 2.  Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.

Authors:  I G McKeith; E K Perry; R H Perry
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

3.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

Review 4.  Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature.

Authors:  Eseosa T Ighodaro; Gregory A Jicha; Frederick A Schmitt; Janna H Neltner; Erin L Abner; Richard J Kryscio; Charles D Smith; Taylor Duplessis; Sonya Anderson; Ela Patel; Adam Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

5.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

6.  Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

7.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  A 2-process model for neuropathology of Alzheimer's disease.

Authors:  Dan Mungas; Rochelle Tractenberg; Julie A Schneider; Paul K Crane; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-09-27       Impact factor: 4.673

9.  Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.

Authors:  Patricia A Boyle; Lei Yu; Sukriti Nag; Sue Leurgans; Robert S Wilson; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

10.  Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease.

Authors:  D J Connor; D P Salmon; T J Sandy; D Galasko; L A Hansen; L J Thal
Journal:  Arch Neurol       Date:  1998-07
View more
  40 in total

Review 1.  Biomarkers for neurodegenerative diseases.

Authors:  Oskar Hansson
Journal:  Nat Med       Date:  2021-06-03       Impact factor: 53.440

2.  The long road to in vivo diagnosis of chronic traumatic encephalopathy.

Authors:  Kristen Dams-O'Connor
Journal:  Brain Commun       Date:  2021-03-10

3.  Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.

Authors:  Sebastian E Sattui; Mangala Rajan; Sarah B Lieber; Geyanne Lui; Madeline Sterling; Jeffrey R Curtis; Lisa A Mandl; Iris Navarro-Millán
Journal:  Semin Arthritis Rheum       Date:  2021-01-05       Impact factor: 5.532

4.  Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects.

Authors:  David S Knopman; Emily S Lundt; Terry M Therneau; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Bradley F Boeve; David T Jones; Jon Graff-Radford; Sabrina M Albertson; Christopher G Schwarz; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

5.  Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.

Authors:  Clifford R Jack; Heather J Wiste; Terry M Therneau; Stephen D Weigand; David S Knopman; Michelle M Mielke; Val J Lowe; Prashanthi Vemuri; Mary M Machulda; Christopher G Schwarz; Jeffrey L Gunter; Matthew L Senjem; Jonathan Graff-Radford; David T Jones; Rosebud O Roberts; Walter A Rocca; Ronald C Petersen
Journal:  JAMA       Date:  2019-06-18       Impact factor: 56.272

Review 6.  Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.

Authors:  Costantino Iadecola; Marco Duering; Vladimir Hachinski; Anne Joutel; Sarah T Pendlebury; Julie A Schneider; Martin Dichgans
Journal:  J Am Coll Cardiol       Date:  2019-07-02       Impact factor: 24.094

Review 7.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

8.  Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations.

Authors:  Lilah M Besser; Merilee A Teylan; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2020-03-01       Impact factor: 3.685

9.  Cholinergic White Matter Lesions, AD-Signature Cortical Thickness, and Change in Cognition: The Northern Manhattan Study.

Authors:  Michelle R Caunca; Karen Siedlecki; Ying Kuen Cheung; Noam Alperin; Sang H Lee; Mitchell S V Elkind; Ralph L Sacco; Clinton B Wright; Tatjana Rundek
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-07-13       Impact factor: 6.053

10.  Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons.

Authors:  Lei Yu; Patricia A Boyle; Robert J Dawe; David A Bennett; Konstantinos Arfanakis; Julie A Schneider
Journal:  Neurology       Date:  2019-11-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.